BridgeMD
New treatment option for Effects of Menstrual Products on the Vaginal Microbiome
Official title Improving Menstrual and VAginal Health for All
ClinicalTrials.gov ID: NCT06646185
What this study is testing
- What it's testing
- A three-period crossover trial will study the effects of short-term use of 3 menstrual products (menstrual pad, tampon, menstrual cup) on the bacterial composition of the vaginal microbiome in three countries (Peru, Cameroon, and Switzerland). Each crossover period consists of two menstrual cycles, thus resulting in a 6-month trial.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 35, women only. Healthy volunteers may be eligible.
You may be able to join if
- able to provide informed consent;
- aged 18-35;
- residing in the recruitment region and expecting to reside in the same region for at least six months following recruitment (Yaoundé/ Gounougou...
- are native speakers or are able to read and understand one of the following languages in each respective country (German, French, Italian, English or...
- had menstrual cycles of 21-35 days for at least the last 4 months;
You likely can't join if
- experienced a menstrual abnormality with any of the menstrual cycles in the last 4 months (such as oligomenorrhea or amenorrhea, or bleed more than 7...
- are pregnant or actively trying to become pregnant;
- are breastfeeding;
- used antibiotics and/or vaginal antifungals in the last 30 days prior to recruitment;
- had a vaginal birth in the last 6 months;
- vaginal surgery, perineal surgery, uterine surgery, miscarriage or abortion in the last 6 months;
See the full eligibility criteria
- able to provide informed consent;
- aged 18-35;
- residing in the recruitment region and expecting to reside in the same region for at least six months following recruitment (Yaoundé/ Gounougou, Cameroon; Loreto/Lima/Maynas provinces, Peru; or Basel-Landschaft and...
- are native speakers or are able to read and understand one of the following languages in each respective country (German, French, Italian, English or Spanish in Switzerland; French or English in Cameroon; Spanish in...
- had menstrual cycles of 21-35 days for at least the last 4 months;
- had menses which lasted at least 3 days for at least the last 4 months.
- experienced a menstrual abnormality with any of the menstrual cycles in the last 4 months (such as oligomenorrhea or amenorrhea, or bleed more than 7 days a month);
- are pregnant or actively trying to become pregnant;
- are breastfeeding;
- used antibiotics and/or vaginal antifungals in the last 30 days prior to recruitment;
- had a vaginal birth in the last 6 months;
- vaginal surgery, perineal surgery, uterine surgery, miscarriage or abortion in the last 6 months;
- history of Toxic Shock Syndrome ;
- positive to detection of the toxic shock syndrome toxin-1 gen (tst) using Polymerase Chain Reaction (PCR);
- Intrauterine device in situ;
- under medication (treatment against infectious or chronic disease) at the time of recruitment or during the 3 weeks prior to recruitment;
- clinical symptoms of vaginal infection;
- smoker.
The study team makes the final eligibility decision.
Where it's taking place
- Yaoundé, Yaoundé, Cameroon
- Iquitos, Iquitos, Peru
- Allschwil, Allschwil, Switzerland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 35 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Yaoundé, Yaoundé, Cameroon; Iquitos, Iquitos, Peru; Allschwil, Allschwil, Switzerland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.